Fatores preditivos de resposta a azatioprina em pacientes com doença de Crohn suboclusiva
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
Background: Despite recent advances in the treatment of patients with Crohn's
disease (CD), occlusive and subocclusive symptoms observed in the presence of
clinically significant stenosis remains a challenging clinical problem. In inflammatory
bowel diseases (IBD), the identification of factors associated with reduced risk of
surgery in this context is important.
Materials and methods: In this retrospective study, we evaluated the possible
predictive factors, including inflammatory markers associated with reduced need for
surgical intervention in patients with CD who presented the first episode of clinically
solved subocclusion and treated subsequently with azathioprine (AZA) for three
years.
Results: Thirty-six patients with subocclusive CD were included, of these, 24 has not
required bowel resection. No demographic or clinical data associated with the
response to AZA. Only C reactive protein (CRP) was correlated with the
effectiveness of AZA. For each increase of 1 mg CRP, there was a reduction of
surgery risk in 8% (RR 0.92, CI 0.86-0.98; P = 0.008). The CRP group> 6 (elevated)
had 81% of surgery risk reduction compared to PCR group <6 (OR 0.19 CI 0.05-0.64;
P = 0.008).
Conclusions: Patients with elevated CRP has a lower rate of surgery in the medium
and long term during therapy with AZA. CRP can identify patients with inflammatory
stenosis and responsive to clinical treatment.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
